Swedish Orphan Biovitrum A/S
Public limited companyCVR 19179079Kgs.LyngbyActive
Swedish Orphan Biovitrum A/S is a public limited company, based in Kgs.Lyngby, active in wholesale of pharmaceutical goods and nursing supplies, founded in 1996. Net profit fell 28% from 2024 to 2025, ending at DKK 3.3m.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesFinancials: 2025 against 2024
- Gross profit fell 13% (2024 → 2025), to DKK 18m.
- Net profit fell 28% (2024 → 2025), to DKK 3.3m.
- Equity rose 9% (2024 → 2025), to DKK 39.5m.
Employees
- 4 more employees than a year earlier: 12 (08/2026) against 8 (08/2025).
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2020–2025 · amounts in DKK thousandEquity and net profit
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change | |
|---|---|---|---|---|---|---|---|
| Revenue | not stated | not stated | not stated | not stated | not stated | not stated | – |
| Gross profit | 39,028 | 32,623 | 23,486 | 22,183 | 20,724 | 18,018 | −13.1% |
| Operating profit (EBIT) | 5,103 | 3,896 | 3,644 | 4,234 | 4,575 | 3,332 | −27.2% |
| Profit before tax | 5,533 | 4,318 | 4,231 | 5,510 | 5,999 | 4,377 | −27% |
| Net profit | 4,278 | 3,350 | 3,173 | 4,188 | 4,570 | 3,269 | −28.5% |
| Total assets | 36,717 | 33,718 | 32,145 | 36,485 | 40,743 | 44,080 | +8.2% |
| Equity | 20,946 | 24,295 | 27,469 | 31,656 | 36,227 | 39,496 | +9% |
| Liabilities | 15,771 | 9,423 | 4,676 | 4,829 | 4,517 | 4,584 | +1.5% |
| Cash and cash equivalents | 1 | 0 | 2,450 | 3,404 | 7,614 | 2,934 | −61.5% |
| Average number of employees | 14 | 15 | 12 | 10 | 10 | 8 | −20% |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Signals from the financial statements
calculated from the 2025 figuresProfit for five years in a row
Net result has been positive in 2021–2025.
How is this calculated?
Net result is positive in the five latest annual reports in a row.
The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.
Annual reports
6 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 01/01/2025 – 31/12/2025 | 09/06/2026 | The company | PDF not statedXBRL |
| 2024 | 01/01/2024 – 31/12/2024 | 04/07/2025 | The company | PDF not statedXBRL |
| 2023 | 01/01/2023 – 31/12/2023 | 25/06/2024 | The company | PDF not statedXBRL |
| 2022 | 01/01/2022 – 31/12/2022 | 21/06/2023 | The company | PDF not statedXBRL |
| 2021 | 01/01/2021 – 31/12/2021 | 29/06/2022 | The company | PDF not statedXBRL |
| 2020 | 01/01/2020 – 31/12/2020 | 23/06/2021 | The company | PDF not statedXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
232 companies in the databaseComparison with the other companies in wholesale of pharmaceutical goods and nursing supplies based on the latest financial year.
Industry median: gross profit DKK 11.2m, net profit DKK 1.8m, equity DKK 9.6m, 9 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with fewer than 20 employees69,967 companies in the comparison | No. 1,793of 69,742 Better than 97% | No. 3,665of 69,964 Better than 95% |
| Same industry and fewer than 20 employees150 companies in the comparison | No. 24of 150 Better than 85% | No. 13of 150 Better than 92% |
| Companies that are at least 30 years old10,276 companies in the comparison | No. 3,030of 10,152 Better than 70% | No. 2,339of 10,275 Better than 77% |
| All companies of type A/S18,025 companies in the comparison | No. 6,416of 17,786 Better than 64% | No. 4,174of 18,024 Better than 77% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Wholesale of pharmaceutical goods and nursing supplies- Swedish Orphan Biovitrum A/SDKK 18m
- Ambu A/SDKK 3.6bn
- Stada Nordic ApSDKK 687m
- Swedish Orphan Biovitrum A/SDKK 3.3m
- Ambu A/SDKK 609m
- Stada Nordic ApSDKK 54.6m
- Swedish Orphan Biovitrum A/SDKK 39.5m
- Ambu A/SDKK 6bn
- Stada Nordic ApSDKK 346.3m
- Swedish Orphan Biovitrum A/S12
- Ambu A/S619
- Stada Nordic ApS51
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- Swedish Orphan Biovitrum International AB100%
Management
4 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Bjørn Gustaf Östen Berglund | Director | 12/09/2017 |
Board of directors
| Name | Role | Appointed |
|---|---|---|
| Bjørn Gustaf Östen Berglund | Board member | 12/09/2017 |
| Karl Henrik Stenqvist | Board member | 09/08/2018 |
| Soufiane Fahmy | Board member | 02/11/2020 |
- Founders
- Swedish Orphan AB
Former management (24)
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| Lars Uno Larsson | Board member | 08/02/1996 | 27/09/2002 |
| Hans-Erik Almbo | Chair of the board | 08/02/1996 | 30/03/2000 |
| Gunnar Wilhelm Paro | Board member | 08/02/1996 | 02/06/1997 |
| Bo Jesper Hansen | Chair of the board | 27/09/2002 | 06/05/2010 |
| Bo Jesper Hansen | Director | 27/09/2002 | 27/09/2002 |
| Lena Storm Christensen | Board member | 27/09/2002 | 10/06/2003 |
| Lena Storm Christensen | Director | 27/09/2002 | 14/06/2003 |
| Pär Gustav Östensjö | Board member | 27/09/2002 | 29/04/2005 |
| Ulf Blangsted Henriksen | Board member | 10/06/2003 | 29/04/2005 |
| Ulf Blangsted Henriksen | Director | 14/06/2003 | 29/04/2005 |
| Lisbeth Hansen | Board member | 29/04/2005 | 01/05/2009 |
| Lisbeth Hansen | Director | 29/04/2005 | 30/04/2009 |
| Janne Antti Laine | Board member | 29/04/2005 | 16/09/2007 |
| Gitte Nøhr Ludvig | Board member | 01/05/2009 | 12/09/2017 |
| Gitte Nøhr Ludvig | Director | 01/05/2009 | 12/09/2017 |
| Alf Gunnar Martin Nicklasson | Board member | 06/05/2010 | 10/02/2011 |
| Frank Carl Kennet Rooth | Chair of the board | 10/02/2011 | 13/09/2011 |
| Per Anders Edvell | Board member | 10/02/2011 | 11/06/2012 |
| Cameron Geoffrey McDonough | Chair of the board | 13/09/2011 | 19/05/2014 |
| Alan Henry Raffensperger | Board member | 11/06/2012 | 06/07/2017 |
| Mats Olof Wallin | Chair of the board | 19/05/2014 | 09/08/2018 |
| Hege Hellstrøm | Board member | 06/07/2017 | 12/06/2019 |
| Christian Dreger | Board member | 12/06/2019 | 19/11/2019 |
| Philip Alexander Wood | Board member | 19/11/2019 | 02/11/2020 |
Signing rule: Selskabet tegnes af to bestyrelsesmedlemmer i forening eller af den samlede bestyrelse
Address and production units
1 active production unitsSorgenfrivej 17
2800 Kgs.Lyngby
| Production unit | Address | Employees | P number |
|---|---|---|---|
| SWEDISH ORPHAN BIOVITRUM A/S | Sorgenfrivej 17, 2800 Kgs.Lyngby | 12 | 1003711543 |
Purpose
Selskabets formål er udvikling, markedsføring og salg af lægemidler til behandling af sjældne sygdomme, samt konsulent virksomhed indenfor helse- og sygdomsområdet, samt virksomhed beslægtet hermed.
The purpose is quoted from the register in Danish.
Changes year by year
64 registered events20261 changeaccounts 1
- AccountsAnnual report for 2025 published
20251 changeaccounts 1
- AccountsAnnual report for 2024 published
20241 changeaccounts 1
- AccountsAnnual report for 2023 published
20231 changeaccounts 1
- AccountsAnnual report for 2022 published
20221 changeaccounts 1
- AccountsAnnual report for 2021 published
20211 changeaccounts 1
- AccountsAnnual report for 2020 published
20202 changesmanagement 2
- ManagementSoufiane Fahmy appointed board member
- ManagementPhilip Alexander Wood stepped down as board member
20194 changesmanagement 4
- ManagementPhilip Alexander Wood appointed board member
- ManagementChristian Dreger stepped down as board member
- ManagementChristian Dreger appointed board member
- ManagementHege Hellstrøm stepped down as board member
20182 changesmanagement 2
- ManagementKarl Henrik Stenqvist appointed board member
- ManagementMats Olof Wallin stepped down as chair of the board
20176 changesmanagement 6
- ManagementBjørn Gustaf Östen Berglund appointed board member
- ManagementBjørn Gustaf Östen Berglund appointed director
- ManagementGitte Nøhr Ludvig stepped down as director
- ManagementGitte Nøhr Ludvig stepped down as board member
- ManagementHege Hellstrøm appointed board member
- ManagementAlan Henry Raffensperger stepped down as board member
20143 changesmanagement 2 · address 1
- ManagementMats Olof Wallin appointed chair of the board
- ManagementCameron Geoffrey McDonough stepped down as chair of the board
- AddressMoved to Sorgenfrivej 17, 2800 Kgs.Lyngby
20122 changesmanagement 2
- ManagementAlan Henry Raffensperger appointed board member
- ManagementPer Anders Edvell stepped down as board member
20115 changesmanagement 5
- ManagementCameron Geoffrey McDonough appointed chair of the board
- ManagementFrank Carl Kennet Rooth stepped down as chair of the board
- ManagementPer Anders Edvell appointed board member
- ManagementFrank Carl Kennet Rooth appointed chair of the board
- ManagementAlf Gunnar Martin Nicklasson stepped down as board member
20104 changesname 1 · management 2 · ownership 1
- NameName changed from SWEDISH ORPHAN A/S to SWEDISH ORPHAN BIOVITRUM A/S
- ManagementAlf Gunnar Martin Nicklasson appointed board member
- ManagementBo Jesper Hansen stepped down as chair of the board
- OwnershipSwedish Orphan Biovitrum International AB registered as owner (100%)
20094 changesmanagement 4
- ManagementGitte Nøhr Ludvig appointed director
- ManagementGitte Nøhr Ludvig appointed board member
- ManagementLisbeth Hansen stepped down as board member
- ManagementLisbeth Hansen stepped down as director
20071 changemanagement 1
- ManagementJanne Antti Laine stepped down as board member
20056 changesmanagement 6
- ManagementJanne Antti Laine appointed board member
- ManagementLisbeth Hansen appointed director
- ManagementLisbeth Hansen appointed board member
- ManagementUlf Blangsted Henriksen stepped down as director
- ManagementUlf Blangsted Henriksen stepped down as board member
- ManagementPär Gustav Östensjö stepped down as board member
20034 changesmanagement 4
- ManagementUlf Blangsted Henriksen appointed director
- ManagementLena Storm Christensen stepped down as director
- ManagementUlf Blangsted Henriksen appointed board member
- ManagementLena Storm Christensen stepped down as board member
20027 changesmanagement 7
- ManagementBo Jesper Hansen appointed director
- ManagementBo Jesper Hansen stepped down as director
- ManagementPär Gustav Östensjö appointed board member
- ManagementLena Storm Christensen appointed director
- ManagementLena Storm Christensen appointed board member
- ManagementBo Jesper Hansen appointed chair of the board
- ManagementLars Uno Larsson stepped down as board member
20011 changeaddress 1
- AddressMoved to Wilders Plads 5, 1403 København K
20002 changesname 1 · management 1
- NameName changed from ORPHAN DENMARK A/S to SWEDISH ORPHAN A/S
- ManagementHans-Erik Almbo stepped down as chair of the board
19971 changemanagement 1
- ManagementGunnar Wilhelm Paro stepped down as board member
19964 changesfounded 1 · management 3
- FoundedRegistered as ORPHAN DENMARK A/S
- ManagementHans-Erik Almbo appointed chair of the board
- ManagementGunnar Wilhelm Paro appointed board member
- ManagementLars Uno Larsson appointed board member
Related companies
Same industry in Lyngby-Taarbæk
- Dentsply Ih A/S17 employees
- Blue Surgical ApS5 employees
- Danamedic ApS4 employees
- Aceso Nordic ApS3 employees
- Unigroup ApS3 employees
- Wellspect ApS3 employees
Same people in management
- Hav Torvehallerne A/Svia Lisbeth Hansen
- Specific Pharma A/Svia Ulf Blangsted Henriksen
- Airco Process Technology A/Svia Bo Jesper Hansen
- Paranova Pack ApSvia Ulf Blangsted Henriksen
- Vivostat A/Svia Bo Jesper Hansen
- Reapplix A/Svia Bo Jesper Hansen
Largest in the industry
- Ambu A/SDKK 3.6bn
- Stada Nordic ApSDKK 687m
- Nomeco A/SDKK 683m
- Orifarm Supply A/SDKK 538.5m
- Novo Nordisk Denmark A/SDKK 497.5m
- Sandoz A/SDKK 260.2m
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026.